Viewing Study NCT01028495

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 1:37 PM

Ignite Modification Date: 2025-12-28 @ 2:09 AM

Study NCT ID: NCT01028495

Status: COMPLETED

Last Update Posted: 2019-09-12

First Post: 2009-12-07

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic Cancer

Sponsor: Rexahn Pharmaceuticals, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module